NCT04579380 2025-12-19Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsSeagen Inc.Phase 2 Active not recruiting217 enrolled 19 charts
NCT00217464 2015-04-16Fulvestrant in Treating Patients With Recurrent Prostate CancerRoswell Park Cancer InstitutePhase 2 Terminated17 enrolled 6 charts
NCT00476645 2014-08-05Fulvestrant in Hormone Refractory Prostate CancerStanford UniversityPhase 2 Completed10 enrolled 8 charts